Skip to main content

Table 4 Result data from first 12 months of Xpert MTB/RIF implementation in nine countries

From: Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries

Xpert site Tests MTB Positive Rifampicin Failed Tests Type of failed test MTB + w/o failed tests
   N % Sensitive Indeterminate Resistant n % Error Invalid No result
     n % N % n %    N % n % n %  
Bangladesh 1428 286 20.0% 249 87.1% 11 3.8% 26 9.1% 99 6.9% 85 85.9% 10 10.1% 4 4.0% 21.5%
Cambodia 3697 768 20.8% 741 96.5% 22 2.9% 5 0.7% 439 11.9% 169 38.5% 264 60.1% 6 1.4% 23.6%
DR Congo 6348 567 8.9% 498 87.8% 17 3.0% 30 5.3% 1032 16.3% 868 84.1% 107 10.4% 57 5.5% 10.7%
Kenya 2803 258 9.2% 238 92.2% 11 4.3% 9 3.5% 266 9.5% 240 90.2% 23 8.6% 3 1.1% 10.2%
Malawi 6258 632 10.1% 602 93.5% 9 1.4% 21 3.3% 853 13.6% 546 64.0% 265 31.1% 42 4.9% 11.7%
Moldova 11472 1965 17.1% 1227 62.4% 48 2.4% 690 35.1% 673 5.9% 387 61.7% 105 15.6% 181 26.9% 18.2%
Mozambique 6823 910 13.3% 826 90.8% 18 2.0% 66 7.3% 871 12.8% 521 59.8% 216 24.8% 134 15.4% 15.3%
Nepal 6943 1376 19.8% 1257 91.4% 14 1.0% 105 7.6% 744 10.7% 409 55.0% 148 19.9% 187 25.1% 22.2%
Pakistan 2201 433 19.7% 390 90.1% 13 3.0% 30 6.9% 130 5.9% 77 59.2% 37 28.5% 16 12.3% 20.9%
All Countries 47973 7195 15.0% 6028 83.8% 163 2.3% 982 13.6% 5107 10.6% 3302 64.7% 1175 23.0% 630 12.3% 16.8%
South Africa a 1180669 171792 14.6% 155811 90.7% 2443 1.4% 12266 7.1% 32561 2.8%        15.0%
  1. aReference 26. Data for South Africa is presented as a comparison after 25 months of implementation.